Technical Analysis for TSVT - 2seventy bio, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Flat | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Support | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| 50 DMA Support | Bullish | -4.00% | |
| Bollinger Band Squeeze | Range Contraction | -4.00% | |
| Up 3 Days in a Row | Strength | -4.00% | |
| Up 4 Days in a Row | Strength | -4.00% | |
| Crossed Above 50 DMA | Bullish | -1.44% | |
| Bollinger Band Squeeze | Range Contraction | -1.44% | |
| BB Squeeze + Upper Band Touch | Range Contraction | -1.44% |
| Alert | Time |
|---|---|
| 10 DMA Support | 1 day ago |
| Outside Day | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Down 5% | 1 day ago |
| Fell Below 50 DMA | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2seventy bio, Inc. operates independently of bluebird bio, Inc. as of November 4, 2021.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.69 |
| 52 Week Low | 1.535 |
| Average Volume | 1,135,562 |
| 200-Day Moving Average | 4.25 |
| 50-Day Moving Average | 4.78 |
| 20-Day Moving Average | 4.63 |
| 10-Day Moving Average | 4.71 |
| Average True Range | 0.37 |
| RSI (14) | 50.98 |
| ADX | 11.92 |
| +DI | 23.21 |
| -DI | 22.68 |
| Chandelier Exit (Long, 3 ATRs) | 4.01 |
| Chandelier Exit (Short, 3 ATRs) | 4.56 |
| Upper Bollinger Bands | 5.10 |
| Lower Bollinger Band | 4.17 |
| Percent B (%b) | 0.68 |
| BandWidth | 20.14 |
| MACD Line | -0.02 |
| MACD Signal Line | -0.06 |
| MACD Histogram | 0.0435 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.30 | ||||
| Resistance 3 (R3) | 5.32 | 5.17 | 5.21 | ||
| Resistance 2 (R2) | 5.17 | 5.05 | 5.16 | 5.18 | |
| Resistance 1 (R1) | 4.99 | 4.97 | 4.92 | 4.97 | 5.16 |
| Pivot Point | 4.84 | 4.84 | 4.81 | 4.83 | 4.84 |
| Support 1 (S1) | 4.66 | 4.72 | 4.59 | 4.64 | 4.44 |
| Support 2 (S2) | 4.51 | 4.64 | 4.50 | 4.42 | |
| Support 3 (S3) | 4.33 | 4.51 | 4.39 | ||
| Support 4 (S4) | 4.31 |
